Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Novartis to Cut Costs Further This Year, Epstein Tells Finanz

Novartis AG aims to cut costs by $1 billion in 2011 in its pharmaceuticals division after achieving the same level of savings last year, head of the business David Epstein told Finanz und Wirtschaft in an interview.

The savings will be invested in new products, such as multiple sclerosis drug Gilenya, Lucentis eye drug and cancer drug Afinitor, Epstein told the newspaper.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.